cll14 trial analysis
Published 5 years ago • 594 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
1:14
cll14 trial thoughts
-
1:24
venetoclax plus obinutuzumab in ckt cll: analysis from the cll14 trial
-
4:30
cll14 trial: obinutuzumab venetoclax vs obinutuzumab chlorambucil
-
1:32
cll14: feasibility of fixed-duration frontline therapy in cll
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
1:03
updates from the cll14 and cll2-give trials on cll
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:14
shady eldaif, md - northside hospital
-
10:24
fixed-duration therapy with venetoclax-obinutuzumab in frontline cll
-
7:29
venetoclax obinutuzumab: impact on cll management
-
2:59
clinical trial updates and time-limited therapy in cll
-
2:01
updated follow-up results of the phase iii gaia/cll13 trial
-
8:57
outcomes of sct in t-all and t-lbl
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:18
celestial-tncll: ongoing phase iii study of sonrotoclax zanubrutinib vs ven obi for tn cll
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:12
insights into the optimal management of cll: the importance of patient characteristics